CN111420278A - Intelligent migraine therapeutic apparatus - Google Patents
Intelligent migraine therapeutic apparatus Download PDFInfo
- Publication number
- CN111420278A CN111420278A CN202010287996.4A CN202010287996A CN111420278A CN 111420278 A CN111420278 A CN 111420278A CN 202010287996 A CN202010287996 A CN 202010287996A CN 111420278 A CN111420278 A CN 111420278A
- Authority
- CN
- China
- Prior art keywords
- pin
- chip
- triode
- resistor
- circuit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010027599 migraine Diseases 0.000 title claims abstract description 61
- 208000019695 Migraine disease Diseases 0.000 title claims abstract description 59
- 230000001225 therapeutic effect Effects 0.000 title claims abstract description 29
- 238000011282 treatment Methods 0.000 claims abstract description 34
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 14
- 229910052744 lithium Inorganic materials 0.000 claims description 14
- 238000002560 therapeutic procedure Methods 0.000 claims description 14
- 230000002441 reversible effect Effects 0.000 claims description 12
- 239000003990 capacitor Substances 0.000 claims description 6
- 210000000056 organ Anatomy 0.000 claims description 5
- 239000003814 drug Substances 0.000 abstract description 13
- 238000009434 installation Methods 0.000 abstract description 5
- 238000000034 method Methods 0.000 abstract description 5
- 238000000053 physical method Methods 0.000 abstract description 5
- 229940079593 drug Drugs 0.000 description 11
- 238000010586 diagram Methods 0.000 description 9
- 206010013654 Drug abuse Diseases 0.000 description 8
- 208000011117 substance-related disease Diseases 0.000 description 8
- 230000002460 anti-migrenic effect Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 238000002651 drug therapy Methods 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 102000009025 Endorphins Human genes 0.000 description 2
- 108010049140 Endorphins Proteins 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- 238000011321 prophylaxis Methods 0.000 description 2
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- KJADKKWYZYXHBB-XBWDGYHZSA-N Topiramic acid Chemical compound C1O[C@@]2(COS(N)(=O)=O)OC(C)(C)O[C@H]2[C@@H]2OC(C)(C)O[C@@H]21 KJADKKWYZYXHBB-XBWDGYHZSA-N 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 229940125681 anticonvulsant agent Drugs 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 239000000480 calcium channel blocker Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- SMANXXCATUTDDT-QPJJXVBHSA-N flunarizine Chemical compound C1=CC(F)=CC=C1C(C=1C=CC(F)=CC=1)N1CCN(C\C=C\C=2C=CC=CC=2)CC1 SMANXXCATUTDDT-QPJJXVBHSA-N 0.000 description 1
- 229960000326 flunarizine Drugs 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- IUBSYMUCCVWXPE-UHFFFAOYSA-N metoprolol Chemical compound COCCC1=CC=C(OCC(O)CNC(C)C)C=C1 IUBSYMUCCVWXPE-UHFFFAOYSA-N 0.000 description 1
- 229960002237 metoprolol Drugs 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229940043274 prophylactic drug Drugs 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 229960003712 propranolol Drugs 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- AEQFSUDEHCCHBT-UHFFFAOYSA-M sodium valproate Chemical compound [Na+].CCCC(C([O-])=O)CCC AEQFSUDEHCCHBT-UHFFFAOYSA-M 0.000 description 1
- 229960004394 topiramate Drugs 0.000 description 1
- 229940102566 valproate Drugs 0.000 description 1
- 229960001722 verapamil Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/025—Digital circuitry features of electrotherapy devices, e.g. memory, clocks, processors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36021—External stimulators, e.g. with patch electrodes for treatment of pain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36025—External stimulators, e.g. with patch electrodes for treating a mental or cerebral condition
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02D—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN INFORMATION AND COMMUNICATION TECHNOLOGIES [ICT], I.E. INFORMATION AND COMMUNICATION TECHNOLOGIES AIMING AT THE REDUCTION OF THEIR OWN ENERGY USE
- Y02D30/00—Reducing energy consumption in communication networks
- Y02D30/70—Reducing energy consumption in communication networks in wireless communication networks
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Developmental Disabilities (AREA)
- Hospice & Palliative Care (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Social Psychology (AREA)
- Electrotherapy Devices (AREA)
Abstract
The invention discloses an intelligent migraine therapeutic apparatus which comprises a patch, a component installation panel and a top panel, wherein the component installation panel is fixedly installed on the upper end surface of the patch, the top panel is fixedly installed on the upper end surface of the component installation panel, and the upper end of the top panel is additionally provided with a key switch. The intelligent migraine therapeutic apparatus provided by the invention has the following advantages: the method has the advantages that: the migraine is treated by adopting a physical method, no medicine is needed during treatment, and the treatment result can be fed back to the mobile phone App to display treatment data. The advantages are two: according to the requirements of users, the magnitude of the output current amplitude of the therapeutic circuit is adjusted to switch to a required mode, so that the requirements of the users are met. The advantages are three: the structure is small and exquisite, the use is comfortable and convenient, and the stability of the power-on is high.
Description
Technical Field
The invention relates to the technical field of migraine therapeutic apparatuses, in particular to an intelligent migraine therapeutic apparatus.
Background
Migraine is the most common neurological disorder, characterized by recurrent headache, with gastrointestinal symptoms and sensory fear, as there are disabling headache and related symptoms, migraine significantly impairs quality of life, according to 2013 global disease burden studies, migraine is the sixth most disabling disease in the world. at present, there are no definite means to cure migraine, but various therapeutic approaches are available to control the disease. control of migraine includes acute and prophylactic treatment: the purpose of acute treatment is to block attacks and restore normal function, while prophylactic treatment is to achieve the goal of reducing attack frequency and severity and alleviating the disease. at present, control of migraine is mainly treated with drugs. the most common drugs to block migraine attacks are analgesics, non-steroidal anti-inflammatory drugs (NSAIDs) and triptans. effective prophylactic drugs include β -receptor blockers (e.g.: metoprolol, propranolol, bisoprostolol, dissartan), calcium channel blockers (e.g.: such as flunarizine or verapamil) and anticonvulsants (e.g.: as topiramate and valproate and valproadrench), thus creating a less frequent adverse effect in patients as a medication after chronic migraine therapy of chronic migraine, more frequent medication, and chronic medication, more adverse drug abuse, more adverse effects of the anti-migraine therapy of these drugs such as the anti-migraine therapy of drugs-migraine, the major drugs, the anti-migraine therapy of migraine is not applicable to treat migraine, the major migraine patients's-migraine is not able to treat migraine, the traditional migraine, the traditional migraine therapy of migraine, the traditional migraine therapy of migraine, the drug therapy of migraine, the traditional migraine, the drug therapy of migraine, the drug abuse, the traditional migraine, the drug abuse, the anti-migraine therapy of migraine is not the drug abuse, the drug abuse of migraine is not the drug abuse of migraine, the anti-medication, the anti-migraine is not the drug abuse of drug abuse, the.
Disclosure of Invention
The invention aims to provide an intelligent migraine therapeutic apparatus, which treats migraine by adopting a physical method, does not need medicines during treatment, and can feed back a treatment result to a mobile phone App to display treatment data; the amplitude of the output current of the therapeutic circuit can be adjusted according to the requirements of a user so as to switch to a required mode to meet the requirements of the user; the structure is small and exquisite, the use is comfortable and convenient, and the power-on stability is high, so as to solve the problem that the prior art proposes that the drug therapy is adopted, and the produced adverse reactions are more.
In order to achieve the purpose, the invention provides the following technical scheme: an intelligent migraine therapeutic apparatus comprises a patch, an element installation panel and a top panel, wherein the element installation panel is fixedly installed on the upper end surface of the patch; the components and parts of top panel lower extreme install panel inner chamber integrated microcontroller, power supply circuit, treatment circuit, lithium cell charging circuit, USB interface circuit, touch switch circuit, low-power consumption bluetooth circuit and bee calling organ suggestion circuit additional, power supply circuit, treatment circuit, lithium cell charging circuit, USB interface circuit, touch switch circuit, low-power consumption bluetooth circuit and bee calling organ suggestion circuit all with microcontroller electric connection.
Preferably, the power supply circuit adopts a chip IC1, the model of the chip IC1 is TPS73101, a pin 1 of the chip IC1 is connected to the VBAT + power supply terminal input and to the input terminal of the capacitor C4, a pin 5 of the chip IC1 outputs a 2.4V power supply and is connected to the output terminal of the resistor R4, the input terminal of the resistor R4 is connected to a pin 4 of the chip IC1 and is connected to the input terminal of the resistor R5, and the output terminal of the resistor R5, the output terminal of the capacitor C4 and a pin 2 of the chip IC1 are connected and then grounded.
Preferably, the microcontroller uses chip IC2 as the main chip, pin 28 of chip IC2 is connected to pin 2 of pin bank JP1, pin 21 of chip IC2 is connected to terminal No. 3 of L ED1, and terminal No. 4 of L ED1 is connected to a 2.4V power input.
Preferably, the treatment circuit comprises a triode Q-triode Q and a reverse voltage-withstanding tube D-reverse voltage-withstanding tube D, wherein the base of the triode Q is connected to a pin 8 of a chip IC, the emitter of the triode Q is grounded, the collector of the triode Q is connected to the output end of an inductor 1 and connected to the positive pole of the reverse voltage-withstanding tube D, the input end of the inductor 1 is connected to a power input end VBAT +, the base of the triode Q is connected to a pin 12 of the chip IC, the emitter of the triode Q is grounded, the collector of the triode Q is connected to the negative pole of the reverse voltage-withstanding tube D and connected to the base of the triode Q and the base of the triode Q, the negative pole of the reverse voltage-withstanding tube D is connected to the input end of a resistor 16, the output end of the resistor R is connected to a pin 19 of the chip IC, the emitter of the triode Q is connected to the base of the triode Q, the collector of the triode Q is connected to the collector of the triode Q and then connected to the TREAT-OUT- + terminal output terminal, the emitter of the triode Q is connected to the base of the emitter of the triode Q, the collector of the triode Q, the collector of the triode Q is connected to the base of the triode Q, the collector of the triode Q, the collector of the triode Q and the collector of the triode Q, the collector of the triode Q is connected to the collector of the triode Q, the collector of the triode Q is connected to the emitter of the collector of the triode Q, the collector of the triode Q is connected to the collector of the emitter of the triode Q, the collector of the.
Preferably, the lithium battery charging circuit adopts a chip IC3 as a main chip, a pin 1 of a chip IC3 is connected to a No. 1 terminal of L ED1, and a pin 3 of the chip IC3 is connected to a power input end VBAT +.
Preferably, pin 5 of the USB interface circuit is connected to pin 4 of chip IC3, and pin 5 of the USB interface circuit is connected to pin 2 and then grounded.
Preferably, the touch switch circuit comprises a switch SW1, a resistor R6, a resistor R8 and a resistor R9, wherein a pin 1 of the switch SW1 is connected with a pin 2 and then connected with the power input terminal VBAT +, a pin 6 of the switch SW1 is connected with the output terminal of the resistor R6, an input terminal of the resistor R6 is connected with a pin 14 of the chip IC2, a pin 4 of the switch SW1 is connected with the input terminal of the resistor R8, an output terminal of the resistor R8 is connected with the input terminal of the resistor R9 and connected with a pin 16 of the chip IC2, and an output terminal of the resistor R9 is grounded.
Preferably, the low power consumption bluetooth circuit adopts a chip B L E1, a chip B L E1 is BF-BM-4044B4, a pin 15 of a chip B L E1 is grounded, a pin 1 of a chip B L E1 is connected to a pin 2 of a chip IC2, a pin 2 of a chip B L E1 is connected to a pin 3 of a chip IC2, a pin 3 of a chip B L E1 is connected to a pin 26 of a chip IC2, a pin 4 of a chip B L E1 is connected to a pin 27 of a chip IC2, a pin 8 of a chip B L E1 is connected to a pin 15 of a chip IC2, a pin 12 of a chip B L E1 is connected to a pin 24 of a chip IC2, and a pin 13 of a chip B L E1 is connected to a pin 25 of a chip IC 2.
Preferably, the buzzer prompting circuit adopts a buzzer BZ1 and a triode Q13, a pin 1 of the buzzer BZ1 is connected to a 2.4V power supply input end, a pin 2 of the buzzer BZ1 is connected to a collector of the triode Q13, an emitter of the triode Q13 is grounded, a base of the triode Q13 is connected to an output end of a resistor R23, and an input end of the resistor R23 is connected to a pin 4 of a chip IC 2.
Compared with the prior art, the invention has the beneficial effects that: the intelligent migraine therapeutic apparatus provided by the invention has the following advantages:
the method has the advantages that: the migraine is treated by adopting a physical method, medicines are not needed during treatment, the connection is established between the mobile phone App and the low-power-consumption Bluetooth circuit, and the treatment result is fed back to the mobile phone App to display treatment data.
The advantages are two: the magnitude of the current amplitude of the treatment circuit is adjustable, so that the intelligent migraine therapeutic apparatus has multiple working modes, and the magnitude of the output current amplitude of the treatment circuit is adjusted according to the requirements of a user so as to switch to a required mode, thereby meeting the requirements of the user.
The advantages are three: the electrode plate is small in structure and convenient to use, the bottom surface of the patch is arranged into an inner arc surface shape according to the shape of a human head, the patch can be well attached to the surface of a human body when in use, the use is comfortable, and the electrode plates are effectively attached to the surface of the human body to ensure the stability of electrification and the stability of the treatment process.
Drawings
FIG. 1 is a schematic view of the overall structure of the present invention;
FIG. 2 is a schematic block diagram of the circuit of the present invention;
FIG. 3 is a power supply circuit diagram of the present invention;
FIG. 4 is a diagram of a microcontroller according to the present invention;
FIG. 5 is a therapeutic circuit diagram of the present invention;
FIG. 6 is a circuit diagram of a lithium battery charging circuit according to the present invention;
FIG. 7 is a circuit diagram of a USB interface according to the present invention;
FIG. 8 is a circuit diagram of a touch switch of the present invention;
FIG. 9 is a circuit diagram of the Bluetooth Low energy device of the present invention;
fig. 10 is a buzzer prompting circuit diagram of the present invention.
In the figure: 1. pasting a piece; 2. the component is additionally provided with a panel; 3. a top panel; 4. a key switch; 5. a microcontroller; 6. a power supply circuit; 7. a therapy circuit; 8. a lithium battery charging circuit; 9. a USB interface circuit; 10. a touch switch circuit; 11. a low power consumption Bluetooth circuit; 12. buzzer prompting circuit.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Referring to fig. 1-10, an intelligent migraine therapeutic apparatus includes a patch 1, a component mounting panel 2 and a top panel 3, wherein the component mounting panel 2 is fixedly mounted on an upper end surface of the patch 1, the top panel 3 is fixedly mounted with an upper end surface of the component mounting panel 2, and a key switch 4 is mounted on an upper end of the top panel 3; the components and parts of 3 lower extremes of top panel install panel 2 inner chamber integrated microcontroller 5 additional, power supply circuit 6, treatment circuit 7, lithium battery charging circuit 8, USB interface circuit 9, touch switch circuit 10, bluetooth low energy circuit 11 and bee calling organ suggestion circuit 12 all with microcontroller 5 electric connection.
The power supply circuit 6 adopts a chip IC1, the model of the chip IC1 is TPS73101, a pin 1 of the chip IC1 is connected to a VBAT + power terminal input and to an input terminal of a capacitor C4, a pin 5 of the chip IC1 outputs a 2.4V power and is connected to an output terminal of a resistor R4, an input terminal of the resistor R4 is connected to a pin 4 of the chip IC1 and is connected to an input terminal of the resistor R5, an output terminal of the resistor R5, an output terminal of the capacitor C4 and a pin 2 of the chip IC1 are connected and then grounded, and the power supply circuit 6 provides power for the operation of each operating component.
The microcontroller 5 adopts a chip IC2 as a main chip, a pin 28 of a chip IC2 is connected to a pin 2 of a pin header JP1, a pin 21 of a chip IC2 is connected to a No. 3 terminal of L ED1, and a No. 4 terminal of L ED1 is connected with a 2.4V power supply input end, so that the operation of the treatment circuit 7 is controlled, treatment information is fed back, and an alarm is sounded during abnormal operation.
The therapeutic circuit 7 comprises a triode Q-triode Q, a reverse voltage-withstanding tube D-reverse voltage-withstanding tube D, a base electrode of the triode Q is connected to a pin 8 of a chip IC, an emitting electrode of the triode Q is grounded, a collecting electrode of the triode Q is connected to an output end of an inductor 1 and is connected to a positive electrode of the reverse voltage-withstanding tube D, an input end of the inductor 1 is connected to a power supply input end VBAT +, a base electrode of the triode Q is connected to a pin 12 of the chip IC, an emitting electrode of the triode Q is grounded, a collecting electrode of the triode Q is connected to a negative electrode of the reverse voltage-withstanding tube D and is connected to a base electrode of the triode Q and a base electrode of the triode Q, a negative electrode of the reverse voltage-withstanding tube D is connected to an input end of a resistor R16, an output end of the resistor R is connected to a pin 19 of the chip IC, an emitting electrode of the triode Q is connected to a base electrode of the triode Q, a collecting electrode of the triode Q is connected to a collecting electrode of the triode Q, a TREAT-OUT-, + terminal output terminal, an emitting electrode of the triode Q is connected to a collecting electrode of a triode Q-withstanding transistor Q, an emitter of a collecting electrode of a triode Q-withstanding transistor Q, and a collecting electrode of a micro-triode Q, and a collecting electrode of a collecting transistor Q, and a collecting electrode of a micro-withstanding transistor Q, and a collecting electrode of a micro-triode Q, and a collecting electrode of a collecting transistor Q, and a collecting electrode of a micro-triode Q, and a collecting electrode of a collecting electrode.
The lithium battery charging circuit 8 adopts the chip IC3 as a main chip, the pin 1 of the chip IC3 is connected to the No. 1 terminal of the L ED1, the pin 3 of the chip IC3 is connected to the power input end VBAT +, and the lithium battery charging circuit 8 is used for charging an internal lithium battery.
The touch switch circuit 10 includes a switch SW1, a resistor R6, a resistor R8 and a resistor R9, the switch SW1, i.e., a key switch 4, is mounted on the top of the top panel 3, a pin 1 of the switch SW1 is connected to a pin 2 and then connected to a power input terminal VBAT +, a pin 6 of the switch SW1 is connected to an output terminal of the resistor R6, an input terminal of the resistor R6 is connected to a pin 14 of the chip IC2, a pin 4 of the switch SW1 is connected to an input terminal of the resistor R8, an output terminal of the resistor R8 is connected to an input terminal of the resistor R9 and connected to a pin 16 of the chip IC2, an output terminal of the resistor R9 is connected to ground, and whether the touch switch SW1 of the touch switch.
The low-power-consumption bluetooth circuit 11 adopts a chip B L E1, a chip B L E1 is BF-BM-4044B4 in model number, a pin 15 of a chip B L E1 is grounded, a pin 1 of a chip B L E1 is connected to a pin 2 of a chip IC2, a pin 2 of a chip B L E1 is connected to a pin 3 of a chip IC2, a pin 3 of a chip B L E1 is connected to a pin 26 of a chip IC2, a pin 4 of a chip B L E1 is connected to a pin 27 of a chip IC2, a pin 8 of a chip B L E1 is connected to a pin 15 of a chip IC2, a pin 12 of a chip B L E1 is connected to a pin 24 of a chip IC2, a pin 13 of a chip B L E1 is connected to a pin 25 of a chip IC2, and a connection is established with a mobile phone App through the low-power-consumption bluetooth.
The buzzer prompting circuit 12 adopts a buzzer BZ1 and a triode Q13, a pin 1 of the buzzer BZ1 is connected to a 2.4V power supply input end, a pin 2 of the buzzer BZ1 is connected to a collector of the triode Q13, an emitter of the triode Q13 is grounded, a base of the triode Q13 is connected to an output end of a resistor R23, an input end of the resistor R23 is connected to a pin 4 of a chip IC2, when the microcontroller 5 detects abnormal work, the microcontroller 5 sends an instruction to control the buzzer BZ1 to work, and the buzzer BZ1 gives an alarm.
The intelligent migraine therapeutic apparatus is characterized in that a power supply circuit 6 supplies power for the operation of a microcontroller 5, a therapeutic circuit 7, a USB interface circuit 9, a touch switch circuit 10 and a low-power consumption Bluetooth circuit 11, the touch switch circuit 10 is connected with the microcontroller 5, the on-off of a switch SW1 is controlled by a PWR-EN port and a KEY-MODE port of the microcontroller 5, the switch SW1 is a KEY switch 4, the KEY switch 4 is arranged at the upper end of a top panel 3, when the intelligent migraine therapeutic apparatus is used, the power-on state of the apparatus can be controlled by pressing the KEY switch 4, a pin 1 of a lithium battery charging circuit 8 is connected to a No. 1 terminal of a L ED1, L ED1 is connected to the microcontroller 5, the lithium battery charging circuit 8 serves as a standby power supply for the microcontroller 5, the low-power consumption Bluetooth circuit 11 is connected with the microcontroller 5, the microcontroller 5 sends a control instruction to the low-power consumption Bluetooth circuit 11 through the low-power consumption Bluetooth circuit 11, the control instruction is sent to the outside, a buzzer prompting circuit 12 is connected with the microcontroller 5, and when the microcontroller 5 detects that the operation is abnormal, the buzzer prompting circuit 12 sends a buzzer prompting sound prompting instruction to prompt the buzzer 12.
This intelligence migraine therapeutic instrument need not the medicine during treatment, adopts physical method treatment migraine, establishes to be connected through cell-phone App and low-power consumption bluetooth circuit 11, feeds back the result of treatment to cell-phone App on and shows treatment data, and wherein treatment circuit 7's theory of operation is as follows:
when the micro-controller 5 contacts a human body, the micro-controller 5 controls the HEA-CH and the HEA-CH to output a high level with a specific width to the treatment circuit 7, the treatment circuit 7 discharges to electrically stimulate the human body, when the HEA-CH outputs a high level with a specific width, the triode Q is conducted, the voltage of an emitter of the triode Q is greater than the voltage of a base of the triode Q through the voltage division of a resistor R and a resistor R, the triode Q and the triode Q are conducted, the output current flows out from the emitter of the triode Q and is output after passing through a diode D, an electrode plate which can be connected with an electrode plate of the diode D is attached to the surface of the human body, meanwhile, the HEA-CH outputs a high level with a specific width, the voltage of the emitter of the triode Q is greater than the voltage of a base of the triode Q through the voltage division of the resistor R and the resistor R, the output current flows out from the emitter of the triode Q, the emitter of the triode Q can be output after passing through the diode D, an electrode plate which can be connected with the diode D to the surface of the human body, the electrode plate of the triode Q and a collector of the triode Q is connected with the collector of the transistor Q, the micro-control circuit, when the voltage of the micro-controller is connected with the collector of the electrode plate, the micro-CH, the micro-controller, the collector of the micro-controller, the micro-controller can control the emitter Q, the micro-CH can be connected with the micro-controller can be connected with the collector of the micro-controller, the micro-controller can be connected with the micro-controller, the.
The first mode is as follows: migraine patient mode-pain relief when headache occurs;
and a second mode: endorphin patterns-enhanced endorphin production for prophylactic migraine use;
and a third mode: stress relief mode-relieving stress for people with high working pressure;
and a fourth mode: promoting sleep mode-people who are difficult to fall asleep quickly enter a sleep state;
and a fifth mode: pleasant mode-giving a sense of pleasure to people, making people happy and happy, and improving work, learning, intelligence and creativity.
This intelligence migraine therapeutic instrument structurally has following advantage: the bottom surface of paster 1 sets up to interior camber according to human head type, and attached overhead at the volume that can be fine, installs component and part at the up end of paster 1 and installs panel 2 additional, installs the inner chamber that component installed panel 2 additional at component to adopt top panel 3 to seal reality, play fine guard action to the component, with key switch 4 setting on top panel 3's top, conveniently press, open this intelligence migraine headache therapeutic instrument, overall structure is small and exquisite, convenient to use.
In summary, the intelligent migraine therapeutic apparatus provided by the invention has the following advantages:
the method has the advantages that: the migraine is treated by adopting a physical method, medicines are not needed during treatment, the connection is established between the mobile phone App and the low-power-consumption Bluetooth circuit 11, and the treatment result is fed back to the mobile phone App to display treatment data.
The advantages are two: the current amplitude of the treatment circuit 7 is adjustable, so that the intelligent migraine therapeutic apparatus has multiple working modes, and the output current amplitude of the treatment circuit 7 is adjusted according to the requirements of a user so as to switch to the required mode, thereby meeting the requirements of the user.
The advantages are three: the patch is small in structure and convenient to use, the bottom surface of the patch 1 is arranged into an inner arc surface shape according to the shape of a human head, the patch can be well attached to the surface of a human body when in use, the patch is comfortable to use, and the electrode plates are effectively attached to the surface of the human body to ensure the stability of power-on, thereby ensuring the stability to the treatment process.
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art should be considered to be within the technical scope of the present invention, and the technical solutions and the inventive concepts thereof according to the present invention should be equivalent or changed within the scope of the present invention.
Claims (9)
1. An intelligent migraine therapeutic apparatus is characterized by comprising a patch (1), a component installing panel (2) and a top panel (3), wherein the component installing panel (2) is fixedly installed on the upper end surface of the patch (1), the top panel (3) is fixedly installed with the upper end surface of the component installing panel (2), and the upper end of the top panel (3) is additionally provided with a key switch (4); the utility model provides a low-power consumption Bluetooth device, including panel (2), treatment circuit (7), lithium battery charging circuit (8), USB interface circuit (9), touch switch circuit (10), low-power consumption Bluetooth circuit (11) and bee calling organ suggestion circuit (12), power supply circuit (6), treatment circuit (7), lithium battery charging circuit (8), USB interface circuit (9), touch switch circuit (10), low-power consumption Bluetooth circuit (11) and bee calling organ suggestion circuit (12) all with microcontroller (5) electric connection.
2. The intelligent migraine headache therapy apparatus of claim 1, wherein: the power supply circuit (6) adopts a chip IC1, the model of the chip IC1 is TPS73101, a pin 1 of the chip IC1 is connected with a VBAT + power supply terminal input and is connected to the input end of a capacitor C4, a pin 5 of the chip IC1 outputs a 2.4V power supply and is connected to the output end of a resistor R4, the input end of a resistor R4 is connected to a pin 4 of the chip IC1 and is connected to the input end of the resistor R5, and the output end of the resistor R5, the output end of the capacitor C4 and a pin 2 of the chip IC1 are connected and then grounded.
3. The intelligent migraine headache therapy apparatus according to claim 1, wherein the microcontroller (5) uses chip IC2 as the main chip, pin 28 of chip IC2 is connected to pin 2 of pin bank JP1, pin 21 of chip IC2 is connected to terminal No. 3 of L ED1, and terminal No. 4 of L ED1 is connected to the 2.4V power input terminal.
4. An intelligent migraine therapeutic apparatus according to claim 1, wherein the therapeutic circuit (7) comprises a triode Q-triode Q and a reverse voltage-withstanding tube D-reverse voltage-withstanding tube D, wherein the base of the triode Q is connected to a pin 8 of the chip IC, the emitter of the triode Q is grounded, the collector of the triode Q is connected to the output terminal of the inductor 1 and to the positive electrode of the reverse voltage-withstanding tube D, the input terminal of the inductor 1 is connected to the power input terminal VBAT +, the base of the triode Q is connected to a pin 12 of the chip IC, the emitter of the triode Q is grounded, the collector of the triode Q is connected to the negative electrode of the reverse voltage-withstanding tube D and to the base of the triode Q, the negative electrode of the reverse voltage-withstanding tube D is connected to the input terminal of the resistor R, the output terminal of the resistor R is connected to the input terminal of the resistor 16, the output terminal of the resistor R is connected to a pin 19 of the chip IC, the emitter of the triode Q is connected to the base of the triode Q, the collector of the triode Q is connected to the collector of the triode Q and to the collector of the triode Q is connected to the collector of the transistor Q, and to the collector of the emitter of the triode Q-OUT-collector of the triode Q, the collector of the triode Q is connected to the emitter of the triode Q-emitter of the triode Q, the emitter of the triode Q-emitter of the triode Q is connected to the emitter of the triode Q, the emitter of the base of the triode Q-emitter of the base of the triode Q, the collector of the triode Q, the collector of the triode Q-emitter of the collector of the triode Q is connected to the emitter of.
5. The intelligent migraine therapeutic apparatus according to claim 1, wherein the lithium battery charging circuit (8) uses a chip IC3 as a main chip, pin 1 of the chip IC3 is connected to terminal No. 1 of L ED1, and pin 3 of the chip IC3 is connected to the power input end VBAT +.
6. The intelligent migraine headache therapy apparatus of claim 1, wherein: pin 5 of the USB interface circuit (9) is connected to pin 4 of chip IC3, and pin 5 of USB interface circuit (9) is connected to pin 2 and then grounded.
7. The intelligent migraine headache therapy apparatus of claim 1, wherein: the touch switch circuit (10) comprises a switch SW1, a resistor R6, a resistor R8 and a resistor R9, wherein a pin 1 of the switch SW1 is connected with a pin 2 and then connected with a power supply input end VBAT +, a pin 6 of the switch SW1 is connected with an output end of the resistor R6, an input end of the resistor R6 is connected with a pin 14 of a chip IC2, a pin 4 of a switch SW1 is connected with an input end of the resistor R8, an output end of the resistor R8 is connected with an input end of the resistor R9 and connected with a pin 16 of the chip IC2, and an output end of the resistor R9 is grounded.
8. The intelligent migraine therapeutic apparatus according to claim 1, wherein the Bluetooth low energy circuit (11) is a chip B L E1, the type of the chip B L E1 is BF-BM-4044B4, the pin 15 of the chip B L E1 is grounded, the pin 1 of the chip B L E1 is connected to the pin 2 of the chip IC2, the pin 2 of the chip B L E1 is connected to the pin 3 of the chip IC2, the pin 3 of the chip B L E1 is connected to the pin 26 of the chip IC2, the pin 4 of the chip B2E 2 is connected to the pin 27 of the chip IC2, the pin 8 of the chip B2E 2 is connected to the pin 15 of the chip IC2, the pin 12 of the chip B2E 2 is connected to the pin 24 of the chip IC2, and the pin 13 of the chip B2E 2 is connected to the pin 25 of the chip IC 2.
9. The intelligent migraine headache therapy apparatus of claim 1, wherein: the buzzer prompting circuit (12) adopts a buzzer BZ1 and a triode Q13, a pin 1 of the buzzer BZ1 is connected to a 2.4V power input end, a pin 2 of the buzzer BZ1 is connected to a collector of the triode Q13, an emitter of the triode Q13 is grounded, a base of the triode Q13 is connected to an output end of a resistor R23, and an input end of the resistor R23 is connected to a pin 4 of a chip IC 2.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010287996.4A CN111420278B (en) | 2020-04-14 | 2020-04-14 | Intelligent migraine therapeutic instrument |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010287996.4A CN111420278B (en) | 2020-04-14 | 2020-04-14 | Intelligent migraine therapeutic instrument |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111420278A true CN111420278A (en) | 2020-07-17 |
| CN111420278B CN111420278B (en) | 2023-06-16 |
Family
ID=71554259
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010287996.4A Active CN111420278B (en) | 2020-04-14 | 2020-04-14 | Intelligent migraine therapeutic instrument |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111420278B (en) |
Citations (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4844075A (en) * | 1984-01-09 | 1989-07-04 | Pain Suppression Labs, Inc. | Transcranial stimulation for the treatment of cerebral palsy |
| US4856526A (en) * | 1984-01-09 | 1989-08-15 | Pain Suppression Labs, Inc. | Apparatus and methodology for treatment of headache syndromes |
| JPH03123566A (en) * | 1989-10-07 | 1991-05-27 | Tokyo Electric Co Ltd | Low-frequency therapeutic apparatus |
| US5215086A (en) * | 1991-05-03 | 1993-06-01 | Cyberonics, Inc. | Therapeutic treatment of migraine symptoms by stimulation |
| US20060004423A1 (en) * | 2002-05-09 | 2006-01-05 | Boveja Birinder R | Methods and systems to provide therapy or alleviate symptoms of chronic headache, transformed migraine, and occipital neuralgia by providing rectangular and/or complex electrical pulses to occipital nerves |
| CN2778315Y (en) * | 2005-04-06 | 2006-05-10 | 大庆油田总医院集团 | Dedicated portable electric ion introduction therapeutic device for hyperthyroidism |
| CN101648048A (en) * | 2008-08-12 | 2010-02-17 | 上海理工大学 | Intelligent balloon dilatation therapeutic instrument for cricopharyngeal muscle achalasia |
| CN204121597U (en) * | 2014-09-30 | 2015-01-28 | 华南理工大学 | A kind of portable electronic medical apparatus for treating menalgia |
| CN205055194U (en) * | 2015-06-24 | 2016-03-02 | 华南理工大学 | Electric pulse migraine headache therapeutic instrument |
| CN207562223U (en) * | 2017-03-23 | 2018-07-03 | 广州市千牧电子有限公司 | A kind of intelligence therapeutic equipment for sick headache |
| CN208017932U (en) * | 2017-05-13 | 2018-10-30 | 陕西诺奕生物医药科技有限公司 | A kind of control system through cranial nerve physical therapy apparatus |
| CN108768145A (en) * | 2018-05-25 | 2018-11-06 | 电子科技大学 | High speed half-bridge gate drive circuit suitable for GaN device for power switching |
| JP2019062976A (en) * | 2017-09-28 | 2019-04-25 | 日光精器株式会社 | Low frequency treatment device |
| CN209347931U (en) * | 2018-12-10 | 2019-09-06 | 苏州小蓝医疗科技有限公司 | A kind of patch type headache is easypro to sleep instrument |
-
2020
- 2020-04-14 CN CN202010287996.4A patent/CN111420278B/en active Active
Patent Citations (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4844075A (en) * | 1984-01-09 | 1989-07-04 | Pain Suppression Labs, Inc. | Transcranial stimulation for the treatment of cerebral palsy |
| US4856526A (en) * | 1984-01-09 | 1989-08-15 | Pain Suppression Labs, Inc. | Apparatus and methodology for treatment of headache syndromes |
| JPH03123566A (en) * | 1989-10-07 | 1991-05-27 | Tokyo Electric Co Ltd | Low-frequency therapeutic apparatus |
| US5215086A (en) * | 1991-05-03 | 1993-06-01 | Cyberonics, Inc. | Therapeutic treatment of migraine symptoms by stimulation |
| US20060004423A1 (en) * | 2002-05-09 | 2006-01-05 | Boveja Birinder R | Methods and systems to provide therapy or alleviate symptoms of chronic headache, transformed migraine, and occipital neuralgia by providing rectangular and/or complex electrical pulses to occipital nerves |
| CN2778315Y (en) * | 2005-04-06 | 2006-05-10 | 大庆油田总医院集团 | Dedicated portable electric ion introduction therapeutic device for hyperthyroidism |
| CN101648048A (en) * | 2008-08-12 | 2010-02-17 | 上海理工大学 | Intelligent balloon dilatation therapeutic instrument for cricopharyngeal muscle achalasia |
| CN204121597U (en) * | 2014-09-30 | 2015-01-28 | 华南理工大学 | A kind of portable electronic medical apparatus for treating menalgia |
| CN205055194U (en) * | 2015-06-24 | 2016-03-02 | 华南理工大学 | Electric pulse migraine headache therapeutic instrument |
| CN207562223U (en) * | 2017-03-23 | 2018-07-03 | 广州市千牧电子有限公司 | A kind of intelligence therapeutic equipment for sick headache |
| CN208017932U (en) * | 2017-05-13 | 2018-10-30 | 陕西诺奕生物医药科技有限公司 | A kind of control system through cranial nerve physical therapy apparatus |
| JP2019062976A (en) * | 2017-09-28 | 2019-04-25 | 日光精器株式会社 | Low frequency treatment device |
| CN108768145A (en) * | 2018-05-25 | 2018-11-06 | 电子科技大学 | High speed half-bridge gate drive circuit suitable for GaN device for power switching |
| CN209347931U (en) * | 2018-12-10 | 2019-09-06 | 苏州小蓝医疗科技有限公司 | A kind of patch type headache is easypro to sleep instrument |
Non-Patent Citations (2)
| Title |
|---|
| IFY21CN: "电脉冲治疗仪", pages 1 - 2, Retrieved from the Internet <URL:《维库电子市场网》> * |
| 董春秋: "脑波治疗仪的理论研究与探讨", 《中国优秀硕士学位论文全文数据库 医药卫生科技辑》, no. 11, pages 080 - 38 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111420278B (en) | 2023-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104941064A (en) | Electrical pulse migraine therapeutic instrument | |
| CN103908747B (en) | Ear vagus stimulator | |
| CN103212157B (en) | Bipolar general nerve electric stimulation instrument | |
| CN108939293A (en) | A kind of graphene health-care appliance | |
| CN209751956U (en) | Adjustable Volatility Meter | |
| CN108721779B (en) | Wireless intelligent acupoint reinforcing and reducing multifunctional therapeutic apparatus | |
| CN108721103A (en) | A kind of physiotherapy equipment of the low-frequency pulse acupoint therapy chronic pharyngitis based on Bluetooth communication | |
| CN113143734A (en) | Portable abdomen physiotherapy equipment that shakes | |
| CN202666194U (en) | Multifunctional bladder pelvic floor rehabilitation instrument | |
| CN203183521U (en) | Bipolar universal electrical nerve stimulator | |
| CN205055194U (en) | Electric pulse migraine headache therapeutic instrument | |
| CN111420278A (en) | Intelligent migraine therapeutic apparatus | |
| CN103495261B (en) | Multifunctional therapy apparatus | |
| CN207304839U (en) | A kind of Headphone device for sub-health treatment | |
| CN208525651U (en) | Low frequency nerves and muscles stimulator | |
| CN207591114U (en) | Multifunctional physiotherapy instrument | |
| CN213994590U (en) | Pulse type headache therapeutic apparatus with 2.4G remote control function | |
| CN205814873U (en) | A kind of neuromuscular stimulation therapeutic instrument of function of wireless remote control | |
| CN214971146U (en) | Wireless Bluetooth audio acupoint synchronous treatment electrode pasting device | |
| CN211724420U (en) | Portable ultrasonic low-intermediate frequency conductivity therapeutic instrument | |
| CN203609756U (en) | Electric pulse physiotherapy apparatus | |
| CN2511329Y (en) | Therapeutical device for drug dependence | |
| CN221431925U (en) | Meridian electric stimulation therapeutic instrument | |
| CN222018756U (en) | Electrotherapy earplugs and portable human acupoint massager | |
| CN219250908U (en) | Ball massage instrument |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |